EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease

Alberto Martínez-Castelao, Takehiro Hasegawa iD, Beatriz Fernández-Fernández iD, José Luis Górriz iD, Alberto Ortiz iD, Maria Quero, Gema Fernández-Fresnedo, Jorge-Iván Zamora, Maria Jose Soler iD, José-Carlos Primo-Alvarez, Nicolas Roberto Robles, Norma Inés Venegas und 9 weitere

Clinical Kidney Journal · 01.04.2026 · 19 (4)

DOI: 10.1093/ckj/sfaf352 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Kidney Journal, online erschienen am 09.12.2025. Verfasst von Alberto Martínez-Castelao und 20 weiteren Autor:innen. Beteiligte Einrichtung: Nefrología, Hospital Universitari de Bellvitge, Hospitalet, Barcelona, Spain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Comunidad de Madrid enBiomedicina, ISCIII, RICORS program to RICORS2040.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Chronic kidney disease (CKD) is frequently associated with systemic inflammation. However, the relationship between inflammatory cytokines and CKD progression remains incompletely understood.

Methods

The PROGRESER study (Factores de PROGRESion en Enfermedad Renal) was a multicentre, prospective observational cohort that included patients with CKD stage G3. A total of 17 plasma and 10 urinary inflammatory cytokines were measured in 165 participants, at baseline, 18 months and 36 months, using a fully automated HISCL immune analyser. Unsupervised cluster analysis identified six distinct patient clusters. Associations between cytokine levels and kidney outcomes [estimated glomerular filtration rate (eGFR), urinary albumin-to-creatinine ratio (uACR), KDIGO risk scores, kidney replacement therapy (KRT)], cardiovascular outcomes (cardiovascular hospitalization) and death was assessed during a follow-up of up to 10 years. The primary outcome was a combination of KRT or death.

Results

Plasma levels of 15 cytokines and 6 urinary cytokines differed between patients with CKD and 30 healthy controls. Of these, plasma interleukin (IL)-8 levels were inversely associated with uACR slopes, while IL-22, tumour necrosis factor (TNF)-α and Growth Differentiation Factor 15 (GDF-15) levels showed positive correlations with uACR progression. Additionally, plasma TNF-α and GDF-15 were associated with KRT and/or death with 10 years. Cluster analysis of plasma IL-8, IL-22, TNF-α and GDF-15 identified six distinct patient clusters. Clusters 3 (elevated levels of IL-22, TNF-α, GDF-15), 4 (elevated levels of all four cytokines) and the uncommon Cluster 5 (high GDF-15 only) were associated with worse kidney, cardiovascular and survival outcomes, while Cluster 6 (low cytokine levels) represented patients with slower disease progression and the best long-term outcomes. Over time, patients frequently transitioned to more severe clusters.

Conclusion

In CKD G3 patients, systemic inflammation can be stratified using cytokine profiles. Specific cytokine clusters are linked to faster progression of CKD and cardiovascular disease, and to worse long-term outcomes including kidney failure and mortality.

Schlagwörter

Stichwörter der Autor:innen

IL-22chronic kidney diseasecytokinesdiabetes mellitusoutcomesprogressionsystemic inflammation

Autor:innen und Institutionen

  • Nefrología, Hospital Universitari de Bellvitge, Hospitalet, Barcelona, Spain.
  • RICORS2040, Madrid, Spain.
  • Sysmex R&D Center Europe GmbH, Hamburg, Germany.
  • Department of Nephrology and Hypertension, Health Research Institute-Fundación Jiménez Díaz University Hospital, Universidad Autónoma de Madrid (IIS-FJD, UAM), Madrid, Spain.
  • Departamento de Medicina, Facultad de Medicina, Universidad Autónoma de Madrid, Madrid, Spain.
  • Servicio de Nefrología, Hospital Clínico Universitario Valencia, INCLIVA, Universitat de València, Valencia, Spain.

ORCID-Profile: Takehiro Hasegawa, Beatriz Fernández-Fernández, José Luis Górriz, Alberto Ortiz, Maria Jose Soler, Esteban Poch

Förderung

  • Comunidad de Madrid enBiomedicina
  • ISCIII
  • RICORS program to RICORS2040
  • European Union and SPACKDc
  • European Cooperation in Science and Technology

Zitieren

APA

Martínez-Castelao, A., Hasegawa, T., Fernández-Fernández, B., Górriz, J. L., Ortiz, A., Quero, M., Fernández-Fresnedo, G., Zamora, J. I., Soler, M. J., Primo-Alvarez, J. C., Robles, N. R., Venegas, N. I., Ojeda, F. I., Gil-Paraíso, A., Llorente-Cortijo, I. M., Martínez-Villanueva, C., Poch, E., Sanchez-Rodriguez, J., Li, Y., …, & Navarro-González, J. F. (2026). Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease. Clinical Kidney Journal, 19(4). https://doi.org/10.1093/ckj/sfaf352

Vancouver

Martínez-Castelao A, Hasegawa T, Fernández-Fernández B, Górriz JL, Ortiz A, Quero M, et al. Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease. Clinical Kidney Journal. 2026;19(4). doi:10.1093/ckj/sfaf352

BibTeX
@article{MartnezCastelao2026,
  author = {Martínez-Castelao, Alberto and Hasegawa, Takehiro and Fernández-Fernández, Beatriz and Górriz, José Luis and Ortiz, Alberto and Quero, Maria and Fernández-Fresnedo, Gema and Zamora, Jorge-Iván and Soler, Maria Jose and Primo-Alvarez, José-Carlos and Robles, Nicolas Roberto and Venegas, Norma Inés and Ojeda, Felipe Ignacio and Gil-Paraíso, Antonio and Llorente-Cortijo, Irene Maria and Martínez-Villanueva, Caridad and Poch, Esteban and Sanchez-Rodriguez, Jinny and Li, Yun and Yuko, Saruta and Navarro-González, Juan F},
  title = {Systemic inflammatory profiles are associated with long-term kidney failure and patient mortality in chronic kidney disease},
  journal = {Clinical Kidney Journal},
  year = {2026},
  volume = {19},
  number = {4},
  doi = {10.1093/ckj/sfaf352}
}
Kostenlos starten →